Interesting analysis, except that the SP was significantly higher BEFORE the SH meeting. Up in the .50s I believe. If I recall it was at .40 or so the day of the meeting and dropped after that, never to recover.
As far a the DIAC trial, I would agree that it is a diversion from the true issue of the value of the patent and the deals that may or may not flow from ANSAP. But it is clearly a thorn in the side of the company.
Here is a more interesting question, does it really matter? If DIAC were to win and take over the company, does it really alter the true value of the ANSAP technology? I suppose he would kill the company as he really does not know how to run it, but would he really be stupid enough to kill the Acacia deal? Therefore, does it really matter if he wins since the patent would still be owned by the company. Seems he would go after the stock and let the company run.
Anyway, just food for thought.